NasdaqGM:PREHealthcare
Prenetics Global (PRE) Q1 Loss Widening Tests Bullish Margin Improvement Narrative
Prenetics Global (NasdaqGM:PRE) opened 2026 with Q1 revenue of about US$36 million and a basic EPS loss of US$1.61, while trailing twelve month revenue stood at roughly US$120 million alongside a basic EPS loss of US$3.71. Over recent quarters, revenue has shifted from US$17.31 million in Q1 2025 to US$36.56 million in Q4 2025 and US$35.95 million in Q1 2026, with quarterly basic EPS losses ranging from US$0.80 to US$1.61 over the same stretch. As a result, the spotlight is now firmly on how...